UK experience of Ofatumumab in refractory B-CLL

類似資料

• Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.
  著者:: Chowdhury, O, 等
  出版事項: (2011)
• Ofatumumab retreatment and maintenance in patients with fludarabine-refractory CLL.
  著者:: Osterborg, A, 等
  出版事項: (2012)
• Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial
  著者:: Andrew R. Pettitt, 等
  出版事項: (2020-02-01)
• Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)
  著者:: Hillmen, P, 等
  出版事項: (2014)
• NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome
  著者:: Roberts, C, 等
  出版事項: (2016)